Connected Drug Delivery Devices Market Size Overview by Industry Trends, Share, Growth Factor and Analysis to 2027

Increasing digitalization is anticipated to propel growth of the global connected drug delivery devices market. Fortune Business Insights has recently announced a report, titled “Connected Drug Delivery Devices Market Size, Share and Global Trend By Product Type (Sensors, Integrated devices), Application (Diabetes, Multiple Sclerosis, Asthma and COPD, Hypertension), End Users (Home Care Settings, Hospitals, Surgical Centers) and Geography Forecast till 2026” to study various factors influencing the market’s trajectory. The increasing adoption of mobile apps for medical purposes is expected to increase the growth rate in the market.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/connected-drug-delivery-devices-market-100380

Some of the Main Key Players Covered in the Report:

• Propeller Health
• Cohero Health Inc.
• AliveCor, Inc.
• Teva Pharmaceutical Industries Ltd.
• Phillips-Medisize, Medtronic
• 3M
• Proteus Digital Health, Inc
• West Pharmaceutical Services, Inc

On the basis of region, in 2018 North America accounted for a considerable share in the global market. The region is expected to keep exhibiting impressive growth through the forecast period 2019-2026. The high presence of key market players, gives North America edge over other regional markets for connected drug delivery. Moreover, technological advancements in drug delivery devices is anticipated to contribute towards market expansion. Europe is projected to emerge as one of the lucrative markets. The region is witnessing high demand for home treatment. Furthermore, favorable reimbursement policies will drive the market in the region.

Technological Advancements in Devices to Aid Market Expansion

Factors expected to drive the global market include advantages of the devices such as reimbursement evidence, better dose measurement, and efficient monitoring of the patient. Moreover, recent innovations in connected drug delivery devices are expected to fuel the demand in the market.